Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Michel Vounatsos
Age : 58
Public asset : 18,994,573 USD
Country of residence : Unknown
Linked companies : Biogen Inc. - PerkinElmer, Inc.

Biography of Michel Vounatsos 
Michel Vounatsos is on the board of PerkinElmer, Inc. (United States), L’Institut de RYthmologie et Modélisation Cardiaque and n-Lorem Foundation and Chief Executive Officer & Director at Biogen, Inc. In his past career he occupied the position of President-Primary Care & Customer Business Line at Merck & Co., Inc. Mr. Vounatsos received an MBA from École des Hautes Études Commerciales de Paris.


Current positions of Michel Vounatsos 
Holdings of Michel Vounatsos 
Michel Vounatsos : Personal Network 
Most Read News 
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/13RICHARD BRANSON : Virgin Galactic acknowledges Branson's pre-launch bike ride never happened
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/13ELON MUSK : Musk defends timing of Tesla's $2.6 billion deal for SolarCity
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
09:18aRAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/13BRUNELLO CUCINELLI : Italian luxury group Cucinelli raises 2021 sales forecast again
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
More news


© 2021 People and Ownership :   
Michel Vounatsos : Connections 


Latest news about Michel Vounatsos 
07/22Biogen says uptake on new Alzheimer's drug slower than expected
RE
07/22BIOGEN : says uptake on new Alzheimer's drug slower than expected
RE
06/08BIOGEN : to start shipping Alzheimer's drug in about two weeks
RE
06/08BIOGEN : to start shipping Alzheimer's drug in about two weeks
RE
06/07BIOGEN : Unveils Patient Outreach, Aid Efforts as CEO Defends New Alzheimer Drug's Price
MT
06/07First New Alzheimer's Drug in Nearly Two Decades Is Approved by FDA -- 5th Update
DJ
More news